Leerink Partnrs Predicts Lower Earnings for Ardent Health

Ardent Health, Inc. (NYSE:ARDT) – Equities researchers at Leerink Partnrs lowered their Q2 2025 earnings per share estimates for Ardent Health in a research report issued on Monday, June 23rd. Leerink Partnrs analyst W. Mayo now anticipates that the company will earn $0.22 per share for the quarter, down from their previous forecast of $0.59. The consensus estimate for Ardent Health’s current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health’s Q3 2025 earnings at $0.81 EPS.

Ardent Health (NYSE:ARDT) last announced its earnings results on Tuesday, May 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.21 by $0.08. The company had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Ardent Health had a return on equity of 16.07% and a net margin of 3.73%.

ARDT has been the topic of several other research reports. Mizuho decreased their price target on Ardent Health from $19.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, April 9th. Guggenheim raised their price target on Ardent Health from $16.00 to $18.00 and gave the company a “buy” rating in a report on Friday, May 9th. Royal Bank Of Canada reissued an “outperform” rating and issued a $21.00 price objective on shares of Ardent Health in a report on Thursday, May 15th. Finally, Stephens restated an “overweight” rating and set a $21.00 target price on shares of Ardent Health in a report on Tuesday, May 20th. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $20.67.

Ardent Health Price Performance

Shares of ARDT stock opened at $13.30 on Thursday. The stock’s fifty day moving average is $13.73 and its 200-day moving average is $14.30. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.98 and a current ratio of 2.12. The stock has a market capitalization of $1.90 billion and a PE ratio of 8.16. Ardent Health has a 52 week low of $11.31 and a 52 week high of $20.72.

Institutional Trading of Ardent Health

A number of large investors have recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Ardent Health in the fourth quarter valued at about $27,000. US Bancorp DE bought a new position in shares of Ardent Health in the fourth quarter valued at about $31,000. Morse Asset Management Inc bought a new position in shares of Ardent Health in the first quarter valued at about $36,000. New York State Common Retirement Fund bought a new position in shares of Ardent Health in the fourth quarter valued at about $48,000. Finally, Deutsche Bank AG raised its position in shares of Ardent Health by 1,251.9% in the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company’s stock valued at $49,000 after purchasing an additional 2,654 shares during the period.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.